NEWPATHS
LIVE

Serial Number

98041778

Owner

CSL BEHRING L.L.C.

Attorney

Scott D. Woldow

Filing Date

Jun 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NEWPATHS Trademark

Serial Number: 98041778

NEWPATHS is a trademark filed by CSL BEHRING L.L.C. on June 14, 2023. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

CSL BEHRING L.L.C. (221 trademarks)

1020 FIRST AVENUE
KING OF PRUSSIA, PA 19406

Entity Type: 16

Trademark Details

Filing Date

June 14, 2023

Registration Date

Not Registered

Published for Opposition

April 2, 2024

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis

Educational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis

Providing medical information and treatment information for clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions and immunological conditions play an important role in pathogenesis

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 5, 2025 EX3G
SOU EXTENSION 3 FILED
Nov 5, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 7, 2025 EX2G
SOU EXTENSION 2 FILED
May 7, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
May 7, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2024 EXRA
SOU EXTENSION 1 GRANTED
Nov 5, 2024 EX1G
SOU EXTENSION 1 FILED
Nov 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2024 CNSA
ASSIGNED TO EXAMINER
Feb 20, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2023 NWOS
NEW APPLICATION ENTERED
Jun 17, 2023 NWAP